Changeflow GovPing Government General Class II Recall: nanOss 3D Bone Graft by XTANT ...
Urgent Enforcement Amended Final

Class II Recall: nanOss 3D Bone Graft by XTANT Medical - Incorrect Shelf Life Labeling

Favicon for changeflow.com FDA Device Recalls (Class II)
Filed
Detected
Email

Summary

XTANT Medical Holdings Inc is recalling nanOss 3D Advanced Bone Graft Substitute and nanOss 3D Plus Advanced Bone Graft Substitute products due to incorrect shelf life labeling. The affected products were labeled with a 5-year shelf life, but the approved and validated shelf life is four years. On March 9, 2026, the firm began notifying customers via URGENT MEDICAL DEVICE RECALL letters, instructing consignees to segregate, quarantine, and discontinue use of affected products and return them to Xtant Medical. The recall affects 225 units distributed across CA, CT, DC, KS, MD, NC, NY, TX, and WI, covering four product codes with multiple lot numbers.

Published by FDA on accessdata.fda.gov . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors FDA Device Recalls (Class II) for new government general regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 89 changes logged to date.

What changed

XTANT Medical Holdings Inc initiated a Class II medical device recall for nanOss 3D Advanced Bone Graft Substitute and nanOss 3D Plus Advanced Bone Graft Substitute products after determining that affected units were incorrectly labeled with a 5-year shelf life when the FDA-approved and validated shelf life is four years. The FDA determined the root cause to be an incorrect or missing expiration date. Affected product codes include 90-300-251008, 90-300-25508, 90-300-251004, and 90-400-25508, with multiple lot numbers spanning RP25-0070 through RP25-0128.

Healthcare providers and medical facilities that received nanOss 3D bone graft products should immediately quarantine affected inventory, discontinue use on patients, and contact XTANT Medical to arrange product returns. With 225 units distributed across nine states, any facility using bone void filler materials should verify their inventory against the lot number list. The recall is classified as Open, meaning not all affected products have been corrected or removed from circulation.

What to do next

  1. Segregate and quarantine all affected products to prevent use
  2. Discontinue use of any affected product
  3. Return affected product to Xtant Medical

Archived snapshot

Apr 24, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

Class 2 Device Recall nanOss 3D

- Databases

| |

| 510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards |

| CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC | |

| New Search | ) |

| | Class 2 Device Recall nanOss 3D | |

Date Initiated by Firm March 09, 2026
Date Posted April 21, 2026
Recall Status Open , Classified
Recall Number Z-1897-2026
Recall Event ID 98643
510(K)Number K132050
Product Classification Filler, bone void, calcium compound - Product Code MQV
Product nanOss 3D Advanced Bone Graft Substitute

nanOss 3D Plus Advanced Bone Graft Substitute

90-300-251008: nanOss 3D Advanced Bone Graft Substitute, 25x100x8mm, 20cc
90-300-25508: nanOss 3D Advanced Bone Graft Substitute, 25x50x8mm, 10cc
90-300-251004: nanOss 3D Advanced Bone Graft Substitute, 25x100x4mm, 10cc
90-400-25508: nanOss 3D Plus Advanced Bone Graft Substitute, 25x50x8mm, 10cc |
| Code Information | Part #:
90-300-251008
UDI-DI 00849777012478
Lot #(s):
385486-RP25-0080
387070-RP25-0081
415971-RP25-0077
436563-RP25-0082
436564-RP25-0079
436565-RP25-0076
444927-RP25-0078

Part #:
90-300-25508
UDI-DI 00849777012492
Lot #(s):
387071-RP25-0083
418098-RP25-0084
436199-RP25-0085

Part #:
90-300-251004
UDI-DI 00849777012461
Lot #(s):
401347-RP25-0070
415871-RP25-0073
415872-RP25-0074
416678-RP25-0072
416679-RP25-0071
418509-RP25-0075

Part #:
90-400-25508
UDI-DI 00849777012539
Lot #(s):
445442-RP25-0128 |
| FEI Number | 3005031160 |
| Recalling Firm/
Manufacturer | XTANT Medical Holdings, Inc
664 Cruiser Ln
Belgrade MT 59714-9719 |
| For Additional Information Contact | Michele Dolan
937-847-8400 |
| Manufacturer Reason
for Recall | Products were incorrectly labeled with a 5-year shelf life. The approved and validated shelf life is four years. |
| FDA Determined
Cause | Incorrect or no expiration date |
| Action | On March 9, 2026, the firm began notifying customers via letters titled "URGENT: MEDICAL DEVICE RECALL."

Customers were instructed to segregate and quarantine all affected products to prevent use, and discontinue use of any affected product. Affected product must be returned to Xtant Medical. |
| Quantity in Commerce | 225 |
| Distribution | US Nationwide distribution in the states and territories of CA, CT, DC, KS, MD, NC, NY, TX, and WI. |
| Total Product Life Cycle | TPLC Device Report |

| 1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 The manufacturer has initiated the recall and not all products have been corrected or removed. This record will be updated as the status changes. | |

| 510(K) Database | 510(K)s with Product Code = MQV |

Get daily alerts for FDA Device Recalls (Class II)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from FDA.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
FDA
Filed
March 9th, 2026
Instrument
Enforcement
Branch
Executive
Legal weight
Binding
Stage
Final
Change scope
Substantive

Who this affects

Applies to
Medical device makers Healthcare providers
Industry sector
3345 Medical Device Manufacturing
Activity scope
Product recall response Market withdrawal Labeling correction
Geographic scope
United States US

Taxonomy

Primary area
Medical Devices
Operational domain
Clinical Operations
Compliance frameworks
GxP
Topics
Product Safety Healthcare

Get alerts for this source

We'll email you when FDA Device Recalls (Class II) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!